Turnstone Biologics
TSBX
$2.61
Share price
-0.76%
Change (1 day)
N/A
Change (1 year)
Categories
Operating Margin for Turnstone Biologics (TSBX)
Operating Margin at the end of 2022: -41.87%
According to Turnstone Biologics's latest financial reports and stock price the company's current Operating Margin is -41.87%. At the end of 2022 the company had an Operating Margin of -41.87%.
Operating Margin history for Turnstone Biologics from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -41.87% | -225.86% |
| 2021 | 33.27% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.